Download PDF
Klinische Neurophysiologie 2016; 47(03): 125-130
DOI: 10.1055/s-0042-110805
Originalia
© Georg Thieme Verlag KG Stuttgart · New York

Die REM-Schlafverhaltensstörung bei neurodegenerativen Erkrankungen

REM Sleep Behaviour Disorder in Neurodegenerative Diseases
F. Sixel-Döring
1   Paracelsus-Elena-Klinik Kassel
2   Neurologische Klinik der Philipps-Universität Marburg
,
M.-L. Muntean
1   Paracelsus-Elena-Klinik Kassel
3   Abt. für Klinische Neurophysiologie, Universitätsmedizin Göttingen
› Author Affiliations
Further Information

Publication History

Publication Date:
18 July 2016 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Eine REM-Schlafverhaltensstörung wird polysomnografisch durch Nachweis eines Verlustes der physiologischen Muskelatonie im REM-Schlaf mit sichtbaren REM-assoziierten motorischen Verhaltensauffälligkeiten oder entsprechenden anamnestischen Hinweisen diagnostiziert. In ihrer idiopathischen Form führt sie bei vielen Betroffenen nach im Mittel 14 Jahren zur Manifestation einer neurodegenerativen Erkrankung. Neuropathologisch lag bei 94% einer autopsierten Kohorte eine Synukleinopathie vor. In einer großen Gruppe von de novo Parkinson-Patienten konnte allerdings nur in 25% der Fälle eine REM-Schlafverhaltensstörung gemäß den derzeit gültigen Diagnosekriterien gesichert werden. Eine Korrelation zu einem spezifischen Parkinson-Phänotyp ergab sich nicht. Im Verlauf der Erkrankung nimmt die Manifestation der REM-Schlafverhaltensstörung zu: In einer großen Kohorte schlafgestörter Parkinson-Patienten unter fortlaufender dopaminerger Behandlung zeigten 46% eine REM-Schlafverhaltensstörung, die somit eine wichtige Differenzialdiagnose nächtlicher Verhaltensauffälligkeiten darstellt und wahrscheinlich den Eintritt in eine fortgeschrittenere Phase der Erkrankung signalisiert. Therapieempfehlungen umfassen derzeit Aufklärung und Modifikation der Schlafumgebung, sowie den Einsatz von Clonazepam und Melatonin.

Abstract

REM sleep behaviour disorder (RBD) is diagnosed with polysomnography that detects loss of physiological muscle atonia during REM sleep and the presence of REM-associated abnormal motor behaviours either seen on the video or reported by patients or bed partners. Idiopathic RBD carries the inherent risk of developing neurodegenerative disease after a mean of 14 years. Autopsy results showed synucleinopathy in 94% of cases. However, in a large cohort of de novo patients with Parkinson’s disease, only 25% met the diagnostic criteria of RBD without any correlation to a specific Parkinsonian phenotype at the early stage of motor manifestation. The frequency of RBD apparently increases with disease progression. Analysis of a large cohort of patients with Parkinson’s disease under dopaminergic treatment and experiencing sleep disturbances showed that 46% were affected by RBD. Thus, RBD is not only an important differential diagnosis for abnormal nocturnal behaviours in patients with Parkinson’s disease but may also indicate progression to a more advanced stage of the disease. Apart from information and modification of sleep surroundings, clonazepam and melatonin are recommended for therapy.

Schlüsselwörter

REM-Schlafverhaltensstörung - Diagnosekriterien - Pathophysiologie - neurodegenerative Erkrankungen - Therapieempfehlungen

Key words

REM sleep behaviour disorder - diagnostic criteria - pathophysiology - neurodegenerative disease - therapy
 

  • Literatur

  • 1 Schenck CH, Bundlie SR, Ettinger MG et al. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 1986; 9: 293-308
    PubMedGoogle Scholar
  • 2 Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996; 46: 388-393
    CrossrefPubMedGoogle Scholar
  • 3 American Academy of Sleep Medicine. REM sleep behavior disorder. In: international classification of sleep disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014: 246-253
    Google Scholar
  • 4 Nalamalapu U, Goldberg R, DiPhillipo M et al. Behaviors simulating REM behaviour disorder in patients with severe obstructive sleep apnea. Sleep res 1996; 25: 311
    PubMedGoogle Scholar
  • 5 Provini F, Plazzi G, Tinuper P et al. Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases. Brain 1999; 122: 1017-1031
    CrossrefPubMedGoogle Scholar
  • 6 Sforza E, Zucconi M, Petronelli R et al. REM sleep behavioral disorders. Eur Neurol 1988; 28: 295-300
    PubMedGoogle Scholar
  • 7 Fantini ML, Gagnon JF, Filipini D et al. The effects of pramipexole in REM sleep behavior disorder. Neurology 2003; 61: 1418-1420
    CrossrefPubMedGoogle Scholar
  • 8 Iranzo A, Santamaria J, Rye DB et al. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology 2005; 65: 247-252
    CrossrefPubMedGoogle Scholar
  • 9 Gagnon JF, Bedard MA, Fantini ML et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology 2002; 59: 585-589
    CrossrefPubMedGoogle Scholar
  • 10 Frauscher B, Gschliesser V, Brandauer E et al. Video analysis of motor events in REM sleep behavior disorder. MovDisord 2007; 22: 1464-1470
    PubMedGoogle Scholar
  • 11 Sixel-Döring F, Schweitzer M, Mollenhauer B et al. Intraindividual variability of REM sleep behaviour disorder in Parkinson’s disease: a comparative assessment using a new REM sleep behaviour disorder severity scale (RBDSS) for clinical routine. J Clin Sleep Med 2011; 7: 75-80
    PubMedGoogle Scholar
  • 12 Frauscher B, Iranzo A, Gaig C et al. for the SINBAR Group. Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder. SLEEP 2012; 35: 835-847
    CrossrefPubMedGoogle Scholar
  • 13 Boeve BF, Silber MH, Saper CB et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007; 130: 2770-2788
    CrossrefPubMedGoogle Scholar
  • 14 Lai Y-Y, Hsieh K-C, Nguyen D et al. Neurotoxic lesions at the ventral mesopontine junction change sleep time and muscle activity during sleep: an animal model of motor disorders in sleep. Neuroscience 2008; 154: 431-443
    CrossrefPubMedGoogle Scholar
  • 15 Brooks PL, Peever JH. Impaired GABA and glycine transmission triggers cardinal features of rapid eye movement sleep behaviour disorder in mice. J Neurosci 2011; 31: 7111-7121
    CrossrefPubMedGoogle Scholar
  • 16 Krenzer M, Anaclet C, Vetrivelan R et al. Brainstem and spinal cord circuitry regulating REM sleep and muscle atonia. PLoS One 2011; 6: e24998
    CrossrefPubMedGoogle Scholar
  • 17 Lu J, Shermann D, Devor M et al. A putative flip-flop switch for control of REM sleep. Nature 2006; 441: 589-594
    CrossrefPubMedGoogle Scholar
  • 18 Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of a parkinsonian disorder or dementia in 81% of older males initially diagnosed with idiopathic REM sleep behavior disorder (RBD): 16-year update on a previously reported series. Sleep Med 2013; 14: 744-748
    CrossrefPubMedGoogle Scholar
  • 19 Iranzo A, Molinuevo JL, Santamaria J et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006; 5: 572-577
    CrossrefPubMedGoogle Scholar
  • 20 Postuma RB, Gagnon JF, Vendette M et al. Quantifiying the risk of neurodegenerative disease in diopathic REM sleep behavior disorder. Neurology 2009; 72: 1294-1295
    CrossrefPubMedGoogle Scholar
  • 21 Iranzo A, Valldeoriola F, Lomena F et al. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 2011; 10: 797-805
    CrossrefPubMedGoogle Scholar
  • 22 Stiasny-Kolster K, Doerr Y, Möller JC et al. Combination of “idiopathic” REM sleep behaviour disorder and olfactory dysfunction as possible indicator α-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 2005; 128: 126-13725
    Google Scholar
  • 23 Wu P, Yu H, Peng S et al. Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder. Brain 2014; 137: 3122-3128
    CrossrefPubMedGoogle Scholar
  • 24 Boeve BF, Silber MH, Ferman TJ et al. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med 2013; 14: 754-762
    CrossrefPubMedGoogle Scholar
  • 25 Mollenhauer B, Trautmann E, Sixel-Döring F et al. & the DeNoPa Study Group. Non-motor findings and diagnostic results in de novo Parkinson’s disease subjects of the DeNopa Study. Neurology 2013; 81: 1226-1234
    CrossrefPubMedGoogle Scholar
  • 26 Sixel-Döring F, Trautmann E, Trenkwalder C et al. REM sleep behavioural events (RBE): a new marker for neurodegeneration in early Parkinson’s disease?. SLEEP 2014; 37: 431-438
    CrossrefPubMedGoogle Scholar
  • 27 Kumru H, Santamaria J, Tolosa E et al. Relation between subtype of Parkinson’s disease and REM sleep behavior disorder. Sleep Med 2007; 8: 779-783
    CrossrefPubMedGoogle Scholar
  • 28 Postuma RB, Gagnon JF, Vendette M et al. REM sleep behaviour disorder in Parkinson’s disease is associated with specific motor features. J Neurol Neurosurg Psychiatry 2008; 79: 1117-1121
    CrossrefPubMedGoogle Scholar
  • 29 Boeve BF, Silver MH, Parisi JE et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or Parkinsonism. Neurology 2003; 61: 40-45
    CrossrefPubMedGoogle Scholar
  • 30 Gagnon JF, Postuma MR, Mazza S et al. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol 2006; 5: 424-432
    CrossrefPubMedGoogle Scholar
  • 31 Sixel-Döring F, Zimmermann J, Wegener A et al. The evolution of REM sleep behavior disorder in early Parkinson’s disease. SLEEP submitted
    PubMedGoogle Scholar
  • 32 Muntean ML, Trenkwalder C, Walters AS et al. Sleep Behavioral Events and Dreaming. J Clin Sleep Med 2015;
    PubMedGoogle Scholar
  • 33 Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson’s disease. Neurology 1993; 43: 2227-2229
    CrossrefPubMedGoogle Scholar
  • 34 Sixel-Döring F, Trautmann E, Mollenhauer B et al. Associated factors for REM sleep behavior disorder in Parkinson’s disease. Neurology 2011; 77: 1048-1054
    CrossrefPubMedGoogle Scholar
  • 35 Ozekmekci S, Apaydin H, Kilic E. Clinical features of 35 patients with Parkinson’s disease displaying REM behaviour disorder. Clin Neurol Neurosurg 2005; 107: 306-309
    CrossrefPubMedGoogle Scholar
  • 36 Sinforiani E, Pacchetti C, Zangaglia R et al. REM behavior disorder, hallucinations and cognitive impairment in Parkinson’s disease: a two-year follow-up. Mov Disord 2008; 23: 1441-1444
    CrossrefPubMedGoogle Scholar
  • 37 Sixel-Döring F, Schweitzer M, Mollenhauer B et al. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy. Sleep Med 2009; 10: 407-415
    CrossrefPubMedGoogle Scholar
  • 38 Arnulf I, Merino-Andreu M, Bloch F et al. REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy. Sleep 2005; 28: 349-354
    PubMedGoogle Scholar
  • 39 Sabater L, Gaig C, Gelpi E et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterization of the antigen, and post-mortem study. Lancet Neurol 2014; 13: 575-586
    CrossrefPubMedGoogle Scholar
  • 40 Aurora et al. & the Standards of Practice Committee. Best Practice Guide for the Treatment of REM Sleep Behaviour Disorder (RBD). J Clin Sleep Med 2010; 6: 85-95
    PubMedGoogle Scholar
  • 41 Kunz D, Mahlberg R. A tow-part, double-blind, placebocontrolled trial of exogenous melatonin in REM sleep behaviour disorder. J Sleep Res 2010; 19: 591-596
    CrossrefPubMedGoogle Scholar
  • 42 Howell MJ, Arneson PA, Schenck CH. A novel therapy for REM sleep behaviour disorder (RBD). J Clin Sleep Med 2011; 7: 639-644
    PubMedGoogle Scholar